No profile data available.
Longeveron Inc. (LGVN) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in Miami, United States, with about 38 full-time employees.
It reported revenue of $1.20 million for fiscal year 2025, down 49.9% from fiscal year 2024, and net income of -$22.70 million. Its market capitalization was $7.91 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States.
Longeveron reported $1.20 million in revenue for fiscal year 2025, down 49.9% from $2.39 million in fiscal year 2024.
$7.91 million as of October 9, 2026.
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Senti Biosciences, Inc. (SNTI), Mangoceuticals, Inc. (MGRX), Soligenix, Inc. (SNGX), Can-Fite BioPharma Ltd. (CANF).